外資系大手製薬メーカー Health Outcomes/Real World Evidence Scientist／Sr. Scientist・Principal Scientist・Sr. Principal Scientist・Advisor

資格・要件

Minimum Qualification Requirements:
• An advanced degree, including Ph.D., M.D., or PharmD/Master’s degree with relevant research　and publication experience in an appropriate discipline (e.g., economics, epidemiology, health administration, health services, medicine, pharmacoeconomics, psychology, statistics, or other relevant sciences)
• Strong comprehension and communication skills including the ability to translate and disseminate complex scientific information in a clear and concise manner
• Strong business English and Japanese skill
• Demonstrated ability to influence and collaborate within and across teams
• The ability to think and act globally with a customer focus and a solution orientation.
• The ability to travel domestically and to international locations.
Other Information/Additional Preferences:
• Knowledge and experience of health care systems in major countries as appropriate for the position requirements.
• Understanding of and experience with clinical settings and clinical research.
• Technical and analytic capabilities in the areas of economic modeling, economic evaluation, burden of disease, epidemiology, statistics, health care policy etc.
• Demonstrated project management skills.

職務内容

＜職務内容＞
The purpose of the Research Scientist, Japan Value, Evidence and Outcomes (Japan VEO) is to deliver valuable evidence that addresses health outcomes issues, maximizes product value in Lilly portfolio, and contributes to improvement of people’s health by demonstrating scientific leadership in evidence strategy development, planning, HEOR/RWE study development and execution.

Primary Responsibilities:
Strategy
• Develops and oversees local HEOR/RWE strategy for compounds in the Lilly portfolio in Japan in the relevant therapeutic area(s) that is aligned with local product strategy and global/regional HEOR/RWE strategy.
• Drives sustained integration of HEOR/RWE from early clinical development through commercialization depending on focus of the assigned project or therapeutic area.
• Formulates and drives Patient Focused Outcome, Real World Evidence, and/or economic value strategies for priority products.
• Provides strategic direction to address complex health outcomes challenges.
Study Development and Execution
• Leads local HEOR/RWE evidence planning and execution for individual compounds/products across the development and commercialization lifecycle to support drug development, optimize pricing and access, and maximize post-launch product value in collaboration with local cross functional team and/or global VEO/VEO International.
• Develops and designs HEOR/RWE studies that can address important gaps for the products, is scientifically robust and feasible, and meet relevant quality standards.
• Applies technical expertise appropriate for the role (e.g., scope or depth in statistical analysis, economic modeling, clinical trials, PFO development, observational/ epidemiologic research methodologies) within a therapeutic area.
• Ensure sustainable delivery of planned evidence in a timely manner.
Organizational Leadership and Influence
• Demonstrate scientific leadership in evidence strategy, planning, study development and execution. Links technical expertise with business acumen and establishes and maintains strategic relationships with key internal and external decision makers.
• Effectively integrates with and influences key business partners and external stakeholders to achieve goals and outcomes
• Promote strategic integration into global for both projects and functional activities.
• Can apply unprecedented innovative approaches with taking a risk to deliver best results.
Information Dissemination
• Effectively communicates HO information to internal business partners, the scientific community, and customers.
• Drives research dissemination strategies and leads research communication efforts including abstracts, posters, podium presentations, promotional materials, and manuscripts.
• Plan for, align, and drive application of results/ deliverables to increase the impact of HO work
• Actively participates in shared learning opportunities to effectively share knowledge and experience (both positive and negative) of management tools and other learnings with colleagues and peers, locally and internationally.
Environmental Awareness
• Maintains awareness of significant developments in disease states in the Lilly portfolio and HO field including current HO methodologies and applications, availability in various real world data, relevant regulations, and other issues as appropriate for the position.
• Anticipates and evaluates future market needs and trends for HO information within pertinent therapeutic area and geography of interest.
• Monitors and influences internal and external environmental factors that shape and impact generation and use of HEOR/RWE research.
• Maintains a presence and relationship with the research community related to the relevant areas.
Project Management
• Partner with Project Managers in Japan VEO to ensures projects meet timelines, budget, and scope by coordinating research efforts with cross-functional team and external collaborators as appropriate.

【その他情報】
【勤務時間】8：45～17：30
【諸手当】住宅手当、通勤交通費など
【昇給】有り
【賞与】年一回　個人業績結果及び会社業績結果に基づく業績変動賞与を翌年3月に支給する。
【時間外手当】　支給なし
【清算制フレックス勤務】適応あり。フレキシブルタイム：5時～22時内で勤務。（ただし、一斉休憩を除く）1日の必要最低労働時間：4時間（半日休暇時は2時間）一斉休憩：12時～13時
【在宅勤務制度】有　　　【受動喫煙対策】あり　就業場所　全面禁煙
【休日休暇】完全週休2日制（土・日曜日）、祝日、クリスマス、年末年始・夏期
*年間休日125日、年次有給休暇、慶弔等
【保険】雇用・労災・健康・厚生年金保険
【福利厚生】住宅援助制度、借上社宅制度、リリーグループ補償制度（医療費・歯科医療費補助制度等）
【定年制】有（60歳）
【継続雇用制度】：有（65歳まで）
【有給休暇】
年途中で入社した社員に対する年次有給休暇は、次の入社月の区分に従い入社の翌月1日に付与さる。入社日にかかわらず、その年の12月31日をもって、勤続年数が1年経過したものとみなし、翌年1月1日に翌年度の年次有給休暇が付与される。
入社月　　　　 1-6月　　7月　　　　8月　　　9月　　　10月　　　11月　　12月
付与日数 　10 　　5 　　4 　　3 　　2 　　1 　　　0

【試用期間】 6か月間　　試用期間中での賃金の違いはございません。
【将来的に従事する可能性のある職務内容】会社の定める職務
＜将来的に勤務する可能性のある場所＞会社の定める事業拠点（テレワークを行う場所を含む）